Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-20-046804

Chief Corp. Affairs Officer sold 7,200 shares at $11.81 ($85,018)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jones Aranthan II Chief Corp. Affairs Officer 2020-08-12 Sale −7,200 $11.81 $85,018 75,487 D: show line 1 in the form
Open-market sales · 7,200 sh · avg $11.81 · $85,018
Loading xslF345X03/doc4.xml…